Evidence map›Paper›PMID 20007266›Full record

ArticleJournal of virology2010

The prostate cancer-associated human retrovirus XMRV lacks direct transforming activity but can induce low rates of transformation in cultured cells.

Michael J Metzger, Christiana J Holguin, Ramon Mendoza, A Dusty Miller

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Xenotropic retrovirus Bxv1 in human pancreatic β cell lines.The Journal of clinical investigation · 2016
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Michael J MetzgerFred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA 98109-1024, USA.
Christiana J Holguin
Ramon Mendoza
A Dusty Miller
North Seattle College · USFred Hutch Cancer Center · US

Funding

Research Education About Cancer and Health (REACH) CoreU54CA132381 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KAREN R PETERSON · 2007 to 2026
$25.3M
Undergraduate Student Training in Cancer ResearchU54CA132383 · NCI · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI MICHELE Irene SHUSTER · 2007 to 2026
$21.4M
Northwest Genome Engineering Consortium (Component 1 of 11)UL1DE019582 · NIDCR · SEATTLE CHILDREN'S HOSPITAL · PI SCHARENBERG, ANDREW M. · 2008 to 2011
$3.1M
NCI NIH HHS U54 CA132381NCI NIH HHS U54 CA132383NIDCR NIH HHS UL1 DE019582NIDCR NIH HHS UL1 DE19582
6 · The paper itself

Abstract

The human retrovirus XMRV (xenotropic murine leukemia virus-related virus) is associated with prostate cancer, but a causal relationship has not been established. Here, we have used cultured fibroblast and epithelial cell lines to test the hypothesis that XMRV might have direct transforming activity but found only rare transformation events, suggestive of indirect transformation, even when the target cells expressed the human Xpr1 cell entry receptor for XMRV. Characterization of cells from three transformed foci showed that all were infected with and produced XMRV, and one produced a highly active transforming virus, presumably generated by recombination between XMRV and host cell nucleic acids. Given the sequence similarity of XMRV to mink cell focus-forming (MCF) viruses and the enhanced leukemogenic activity of the latter, we tested XMRV for related MCF-like cytopathic activities in cultured mink cells but found none. These results indicate that XMRV has no direct transforming activity but can activate endogenous oncogenes, resulting in cell transformation. As part of these experiments, we show that XMRV can infect and be produced at a high titer from human HT-1080 fibrosarcoma cells that express TRIM5alpha (Ref1), showing that XMRV is resistant to TRIM5alpha restriction. In addition, XMRV poorly infects NIH 3T3 cells expressing human Xpr1 but relatively efficiently infects BALB 3T3 cells expressing human Xpr1, showing that XMRV is a B-tropic virus and that its infectivity is regulated by the Fv1 mouse locus.

Indexed as

AnimalsAntiviral Restriction FactorsCarrier ProteinsCell LineCell Line, TumorCell Transformation, NeoplasticCell Transformation, ViralCytopathogenic Effect, ViralDogsHumansLeukemia Virus, MurineMaleMiceMink Cell Focus-Inducing VirusesNIH 3T3 CellsProstatic NeoplasmsAntiviral Restriction FactorsCarrier ProteinsReceptors, G-Protein-CoupledReceptors, VirusRecombinant ProteinsTRIM5 protein, humanTripartite Motif ProteinsUbiquitin-Protein LigasesXenotropic and Polytropic Retrovirus ReceptorXPR1 protein, humanXpr1 protein, mouse

Identifiers

PMID20007266
PMCPMC2812358
OpenAlexW2158552395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.